Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 2
2022 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.
Levin SN, Venkatesh S, Nelson KE, Li Y, Aguerre I, Zhu W, Masown K, Rimmer KT, Diaconu CI, Onomichi KB, Leavitt VM, Levine LL, Strauss-Farber R, Vargas WS, Banwell B, Bar-Or A, Berger JR, Goodman AD, Longbrake EE, Oh J, Weinstock-Guttman B, Thakur KT, Edwards KR, Riley CS, Xia Z, De Jager PL; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Levin SN, et al. Ann Clin Transl Neurol. 2021 Apr;8(4):918-928. doi: 10.1002/acn3.51314. Epub 2021 Feb 22. Ann Clin Transl Neurol. 2021. PMID: 33616290 Free PMC article.
Impact of resilience, social support, and personality traits in patients with neuroinflammatory diseases during the COVID-19 pandemic.
Jakimovski D, Kavak KS, Longbrake EE, Levit E, Perrone CM, Bar-Or A, Benedict RH, Riley CS, De Jager PL, Venkatesh S, Walker ELS, Xia Z, Weinstock-Guttman B; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Jakimovski D, et al. Mult Scler Relat Disord. 2022 Dec;68:104235. doi: 10.1016/j.msard.2022.104235. Epub 2022 Oct 9. Mult Scler Relat Disord. 2022. PMID: 36283322 Free PMC article.
Worsening physical functioning in patients with neuroinflammatory disease during the COVID-19 pandemic.
Levit E, Cohen I, Dahl M, Edwards K, Weinstock-Guttman B, Ishikawa T, Kavak K, Leavitt V, Nelson K, Onomichi K, Bar-Or A, Perrone C, Riley C, Venkatesh S, De Jager PL, Xia Z, Longbrake EE; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Levit E, et al. Mult Scler Relat Disord. 2022 Feb;58:103482. doi: 10.1016/j.msard.2021.103482. Epub 2022 Jan 4. Mult Scler Relat Disord. 2022. PMID: 35016114 Free PMC article.
Vaccination Against SARS-CoV-2 in Neuroinflammatory Disease: Early Safety/Tolerability Data.
Epstein S, Xia Z, Lee AJ, Dahl M, Edwards K, Levit E, Longbrake EE, Perrone C, Kavak K, Weinstock-Guttman B, Diallo F, Ricci A, Riley CS, De Jager PL, Farber R, Wesley SF; Multiple Sclerosis Resilience to COVID-19 (MSReCOV) Collaborative. Epstein S, et al. Mult Scler Relat Disord. 2022 Jan;57:103433. doi: 10.1016/j.msard.2021.103433. Epub 2021 Dec 2. Mult Scler Relat Disord. 2022. PMID: 34923427 Free PMC article.